PMC2018 Mobile Header 300x76

Cognitive Enhancers in Dementia: When to Start, What to Expect, and When to Stop

Type: Keynote
Therapeutic: Geriatrics,Neurology,Psychiatry,Mental Health
Thursday May 10
1:50pm to 2:50pm
Location: Lecture Hall 1
Credits: 1 Mainpro+

  • Description

    This lecture will review the indications for treatment of dementia with cognitive enhancers (cholinesterase inhibitors and memantine) based on clinical practice guidelines. The modest improvements in cognition, function and behavior will be emphasized, along with potential adverse events. Emerging evidence on when to discontinue (“deprescribe”) will be also be reviewed.

    Learning Objectives
    • Review the indications for cognitive enhancers in dementia.
    • Be able to initiate and monitor cognitive enhancer therapy for dementia.
    • Review when, and how to deprescribe cognitive enhancers in dementia.

  • Speakers